Hiroki Maehara

410 total citations
31 papers, 294 citations indexed

About

Hiroki Maehara is a scholar working on Biotechnology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroki Maehara has authored 31 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biotechnology, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroki Maehara's work include Cancer Research and Treatments (11 papers), Sarcoma Diagnosis and Treatment (5 papers) and Virus-based gene therapy research (4 papers). Hiroki Maehara is often cited by papers focused on Cancer Research and Treatments (11 papers), Sarcoma Diagnosis and Treatment (5 papers) and Virus-based gene therapy research (4 papers). Hiroki Maehara collaborates with scholars based in Japan, United States and Russia. Hiroki Maehara's co-authors include Fuminori Kanaya, Robert M. Hoffman, Yasunori Tome, Michael Bouvet, Kazuhiro Tanaka, Shuya Yano, Fuminari Uehara, Hiroyuki Tsuchiya, Tetsuju Sekiryu and Naotoshi Sugimoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Hiroki Maehara

26 papers receiving 287 citations

Peers

Hiroki Maehara
Xiafang Chen China
Eun Chun Han South Korea
Tomoko Tsujie Japan
Suet‐Ping Wong United Kingdom
Aby J. Mathew United States
G. Wildhardt Germany
Xinhao Shao United States
Shanawaz M. Ghouse United States
Kathleen N. Riley United States
Xiafang Chen China
Hiroki Maehara
Citations per year, relative to Hiroki Maehara Hiroki Maehara (= 1×) peers Xiafang Chen

Countries citing papers authored by Hiroki Maehara

Since Specialization
Citations

This map shows the geographic impact of Hiroki Maehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Maehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Maehara more than expected).

Fields of papers citing papers by Hiroki Maehara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Maehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Maehara. The network helps show where Hiroki Maehara may publish in the future.

Co-authorship network of co-authors of Hiroki Maehara

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Maehara. A scholar is included among the top collaborators of Hiroki Maehara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Maehara. Hiroki Maehara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Maehara, Hiroki, Yuta Ueno, Takefumi Yamaguchi, et al.. (2025). Artificial intelligence support improves diagnosis accuracy in anterior segment eye diseases. Scientific Reports. 15(1). 5117–5117. 2 indexed citations
3.
Maehara, Hiroki, Keiichiro Tanaka, Yutaka Kato, et al.. (2024). Complement activation products in tears of dry eye and meibomian gland dysfunction. Scientific Reports. 14(1). 43–43. 4 indexed citations
4.
Maehara, Hiroki, et al.. (2024). Efficacy of 3% diquafosol long-acting eye drops in dry eye patients treated for three months. Japanese Journal of Ophthalmology. 68(4). 338–345.
5.
Zakharova, Natalia V., А. С. Кононихин, Medvedev Os, et al.. (2023). Changes in the proteomics of exhaled breath condensate under the influence of inhaled hydrogen in patients with post-COVID syndrome. CARDIOVASCULAR THERAPY AND PREVENTION. 22(3). 3517–3517. 3 indexed citations
6.
Maehara, Hiroki, et al.. (2023). Tear fluid and complement activation products in tears after ocular surgery. BMC Ophthalmology. 23(1). 329–329. 3 indexed citations
7.
Os, Medvedev, С. Д. Варфоломеев, О. А. Свитич, et al.. (2021). Hydrogen inhalation in rehabilitation program of the medical staff recovered from COVID-19. SHILAP Revista de lepidopterología. 20(6). 2986–2986. 13 indexed citations
8.
Tome, Yasunori, et al.. (2021). Reconstruction of the elbow using pedicle joint freezing after wide excision for soft tissue sarcoma: A case report. Molecular and Clinical Oncology. 14(6). 115–115. 1 indexed citations
9.
Furugen, Makoto, Takuro Ariga, H Aoyama, et al.. (2019). Radiation-induced sarcoma in a 10-year survivor with stage IV EGFR-mutated lung adenocarcinoma. Respiratory Medicine Case Reports. 28. 100889–100889.
10.
Sekiryu, Tetsuju, et al.. (2019). Impact of tear metrics on the reliability of perimetry in patients with dry eye. PLoS ONE. 14(9). e0222467–e0222467. 5 indexed citations
11.
Sugano, Yukinori, et al.. (2018). Morphometrical evaluation of the choriocapillaris imaged by swept-source optical coherence tomography angiography. Clinical ophthalmology. Volume 12. 2267–2276. 20 indexed citations
12.
Tsubakimoto, Maho, et al.. (2017). MRI findings and demographics of elastofibroma dorsi: assessment of diffusion-weighted imaging and contrast enhancement patterns. Acta Radiologica. 59(6). 709–715. 10 indexed citations
13.
Uehara, Fuminari, Yukihiko Hiroshima, Shinji Miwa, et al.. (2015). Fluorescence-Guided Surgery of Retroperitoneal-Implanted Human Fibrosarcoma in Nude Mice Delays or Eliminates Tumor Recurrence and Increases Survival Compared to Bright-Light Surgery. PLoS ONE. 10(2). e0116865–e0116865. 8 indexed citations
14.
Uehara, Fuminari, Yasunori Tome, Shuya Yano, et al.. (2013). A color-coded imaging model of the interaction of αv integrin-GFP expressed in osteosarcoma cells and RFP expressing blood vessels in Gelfoam® vascularized in vivo.. PubMed. 33(4). 1361–6. 8 indexed citations
15.
Tanaka, Kazuhiro, Hiroki Maehara, & Fuminori Kanaya. (2012). Vascularized fibular graft for bone defects after wide resection of musculoskeletal tumors. Journal of Orthopaedic Science. 17(2). 156–162. 29 indexed citations
16.
Maehara, Hiroki, et al.. (2010). Reconstruction with Liquid Nitrogen-Treated Autograft after Excision of Osteosarcoma in Distal Femur: A Case Report. Orthopedics & Traumatology. 59(3). 472–475.
17.
Maehara, Hiroki, Tadashi Kaname, Kumiko Yanagi, et al.. (2007). Midkine as a novel target for antibody therapy in osteosarcoma. Biochemical and Biophysical Research Communications. 358(3). 757–762. 31 indexed citations
18.
Kaname, Tadashi, Kumiko Yanagi, Yasutsugu Chinen, et al.. (2007). Mutations in CD96, a Member of the Immunoglobulin Superfamily, Cause a Form of the C (Opitz Trigonocephaly) Syndrome. The American Journal of Human Genetics. 81(4). 835–841. 34 indexed citations
19.
20.
Maehara, Hiroki & Kazuyuki Suzuki. (2005). An Optimal Policy for Condition Monitoring Maintenance with Uncertain Repair. 27(3). 219–230. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiafang Chen Breakdown of academic impact, for papers by Eun Chun Han Breakdown of academic impact, for papers by Tomoko Tsujie Breakdown of academic impact, for papers by Suet‐Ping Wong Breakdown of academic impact, for papers by Aby J. Mathew Breakdown of academic impact, for papers by G. Wildhardt Breakdown of academic impact, for papers by Xinhao Shao Breakdown of academic impact, for papers by Shanawaz M. Ghouse Breakdown of academic impact, for papers by Kathleen N. Riley
Rankless by CCL
2026